1) xeno-lymphoproliferation
异种混合内皮淋巴细胞反应
2) allogenic mixed lymphocyte reaction
异体混合淋巴细胞反应
3) mixed lymphocyte reaction
混合淋巴细胞反应
1.
Application of vital dye CFDA-SE and SNARF-1 to evaluate mixed lymphocyte reaction;
联合应用活体染料CFDA-SE和SNARF-1检测混合淋巴细胞反应
2.
Acceleration of mixed lymphocyte reaction by HCV C-Fc gene-transferred murine dendritic cells;
HCV C-Fc基因转染的小鼠树突状细胞促进混合淋巴细胞反应的作用
3.
Eukaryotic expression of the secretory mOX40-Fc fusion protein and its effects on mixed lymphocyte reaction;
mOX40-Fc的真核表达及其对混合淋巴细胞反应的影响
4) MLR
混合淋巴细胞反应
1.
Comparative study on xeno-and allo-MLRs between human and mice;
人-鼠间同种和异种混合淋巴细胞反应的对比
2.
Objective To explore the biological effects of anti-CD38 monoclonal antibody(1C6) in inhibiting tumor cells and normal human peripheral blood mononuclear cells(PBMCs) proliferation induced by anti-CD3 monoclonal antibody and MLR.
利用抗人CD3单克隆抗体刺激人外周血淋巴细胞增殖、同种异型抗原诱导混合淋巴细胞反应,在加入或未加入抗人CD38单克隆抗体(1C6)的情况下,观察细胞形态并检测3H-TdR掺入量。
3.
To evaluate the biological effects of anti-CD154 and anti-CD80 monoclonal antibodies alone or in combination to modulate the primary and secondary immune responses of CD4+ T cells against the allo-antigens, functional anti-CD154 and/or anti-CD80 mAb were employed in the ex vivo mixed lymphocyte reaction (MLR).
结果显示,1B1和3H8单独或联合应用能不同程度地抑制混合淋巴细胞反应中CD4+T细胞对同种抗原刺激的增殖,下调CD4+T细胞分泌IL-2和IFN-γ,并且在再次反应中能有效诱导CD4+T细胞对同种抗原的免疫低反应性。
5) Mixed leukocyte reaction
混合淋巴细胞反应
1.
Phenotype was assessed with flow cytometry, and the antigen-presenting function was assessed with the mixed leukocyte reaction.
方法:用卵清蛋白建立哮喘模型,利用rmGM-CSF和rmIL-4体外诱导骨髓细胞分化为DCs,流式细胞仪检测DCs表面共刺激分子的表达,混合淋巴细胞反应检测DCs刺激同种异体的T淋巴细胞增殖的能力。
补充资料：异种
1.旧时指同一种族中的其他部落。 2.指异族。 3.指人类以外的其他物种。 4.指动植物的奇特品种。 5.指不同的品种。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条